U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. InterSol Solution/Platelet Additive Solution 3
  1. Approved Blood Products

InterSol Solution/Platelet Additive Solution 3

Product name: InterSol Solution/ Platelet Additive Solution 3
Manufacturer: Fenwal, Inc, 
Intended Use: InterSol solution is an isotonic solution designed to replace a proportion of the plasma used in the storage of AMICUS™-derived leukoreduced apheresis platelets under standard blood banking conditions.
Approval Date: December 9, 2009
Type of submission: New Drug Application
NDA Number: BN080041/0

Production Information

Supporting Documents

Back to Top